CMTM7 inhibits the growth of ESCC and NSCLC cells by suppressing epidermal growth factor receptor-protein kinase B (EGFR-AKT) signaling [4, 5]. This evidence concerns the gene AKT1 and esophageal squamous cell carcinoma.